Evotec SE (EVO) Receivables (2020 - 2026)
Evotec SE's (EVO) quarterly Receivables came in at $156389.4 in Q1 2026, down 32.79% year-on-year from $232688.4 in Q1 2025, and down 18.21% quarter-over-quarter from $191203.5 in Q4 2025.
Evotec SE (EVO) Receivables (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Receivables across 7 years of filings, most recently posting $156389.4 for Q1 2026.
- Receivables for Q1 2026 came in at $156389.4, down 32.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $156389.4 (down 32.79% YoY), and the FY2025 annual result was $191203.5, down 99.85% from the prior year.
- Receivables came in at $156389.4 for Q1 2026 at Evotec SE, down from $191203.5 in the prior quarter.
- In the past five years, Receivables ranged from a high of $179.4 million in Q4 2022 to a low of $126394.3 in Q1 2022.
- The 5-year median for Receivables is $159185.7 (2024), against an average of $31.8 million.
- Peak annual rise in Receivables reached 46.17% in 2025, while the deepest fall reached 99.85% in 2025.
- Evotec SE's Receivables stood at $179.4 million in 2022, then sank by 39.7% to $108.2 million in 2023, then climbed by 15.09% to $124.5 million in 2024, then slumped by 99.85% to $191203.5 in 2025, then fell by 18.21% to $156389.4 in 2026.
- The last three Receivables figures came in at $156389.4 (Q1 2026), $191203.5 (Q4 2025), and $181998.5 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 149.62 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 355.67 Mn |
| 10 | Evotec SE | 570.60 Mn | 570.08 Mn | - | 156,389.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156,389.37 |
| Dec 31, 2025 | 191,203.46 |
| Sep 30, 2025 | 181,998.50 |
| Jun 30, 2025 | 151,706.37 |
| Mar 31, 2025 | 232,688.41 |
| Dec 31, 2024 | 124.52 Mn |
| Sep 30, 2024 | 150,272.67 |
| Mar 31, 2024 | 159,185.68 |
| Dec 31, 2023 | 108.20 Mn |
| Dec 31, 2022 | 179.43 Mn |
| Sep 30, 2022 | 141,794.63 |
| Jun 30, 2022 | 135,183.28 |
| Mar 31, 2022 | 126,394.31 |
| Dec 31, 2021 | 154.12 Mn |
| Sep 30, 2021 | 131,491.72 |
| Dec 31, 2020 | 101.87 Mn |